Cargando…

Association of peripheral immunity with cognition, neuroimaging, and Alzheimer’s pathology

BACKGROUND: Neuroinflammation has been considered to be a driving force of Alzheimer’s disease. However, the association between peripheral immunity and AD has been rarely investigated. METHODS: Separate regression analyses were conducted to explore the associations among peripheral immune markers a...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hou, Jia-Hui, Ou, Ya-Nan, Xu, Wei, Zhang, Peng-Fei, Tan, Lan, Yu, Jin-Tai
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2022
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8830026/ https://www.ncbi.nlm.nih.gov/pubmed/35139899 http://dx.doi.org/10.1186/s13195-022-00968-y

Ejemplares similares

Association between Life’s Simple 7 and cerebrospinal fluid biomarkers of Alzheimer’s disease pathology in cognitively intact adults: the CABLE study
por: Zhao, Yong-Li, et al.
Publicado: (2022)

Effect of HMGCR genetic variation on neuroimaging biomarkers in healthy, mild cognitive impairment and Alzheimer's disease cohorts
por: Cao, Lei, et al.
Publicado: (2016)

Plasma β(2)-microglobulin and cerebrospinal fluid biomarkers of Alzheimer’s disease pathology in cognitively intact older adults: the CABLE study
por: Huang, Yi-Ming, et al.
Publicado: (2023)

Associations of healthy lifestyles with cerebrospinal fluid biomarkers of Alzheimer’s disease pathology in cognitively intact older adults: the CABLE study
por: Hou, Xiao-He, et al.
Publicado: (2021)

Associations of the cerebrospinal fluid hepatocyte growth factor with Alzheimer’s disease pathology and cognitive function
por: Zhao, Li-Jing, et al.
Publicado: (2021)

Effect of CLU genetic variants on cerebrospinal fluid and neuroimaging markers in healthy, mild cognitive impairment and Alzheimer’s disease cohorts
por: Tan, Lin, et al.
Publicado: (2016)

Anaemia and cerebrospinal fluid biomarkers of Alzheimer’s pathology in cognitively normal elders: the CABLE study
por: Yang, Xin-Yu, et al.
Publicado: (2021)

Association between NME8 Locus Polymorphism and Cognitive Decline, Cerebrospinal Fluid and Neuroimaging Biomarkers in Alzheimer's Disease
por: Liu, Ying, et al.
Publicado: (2014)

Effects of Subcortical Atrophy and Alzheimer’s Pathology on Cognition in Elderly Type 2 Diabetes: The Alzheimer’s Disease Neuroimaging Initiative Study
por: Zhang, Wen, et al.
Publicado: (2022)

Association of serum Apolipoprotein B with cerebrospinal fluid biomarkers of Alzheimer’s pathology
por: Hu, Hao, et al.
Publicado: (2020)

Association between methylation of BIN1 promoter in peripheral blood and preclinical Alzheimer’s disease
por: Hu, Hao, et al.
Publicado: (2021)

Association of cerebrospinal fluid neurogranin levels with cognition and neurodegeneration in Alzheimer’s disease
por: Xue, Mei, et al.
Publicado: (2020)

Mutant presenilin-1 deregulated peripheral immunity exacerbates Alzheimer-like pathology
por: Zhu, Yuyan, et al.
Publicado: (2011)

Fasting blood glucose and cerebrospinal fluid Alzheimer’s biomarkers in non-diabetic cognitively normal elders: the CABLE study
por: Ou, Ya-Nan, et al.
Publicado: (2020)

Subtle cognitive impairment as a marker of Alzheimer's pathologies and clinical progression in cognitively normal individuals
por: Shen, Xue‐Ning, et al.
Publicado: (2021)

Prediction of Alzheimer's Pathological Changes in Subjective Cognitive Decline Using the Self-report Questionnaire and Neuroimaging Biomarkers
por: Hong, Yun Jeong, et al.
Publicado: (2019)

Meta-Analysis of Peripheral Blood Apolipoprotein E Levels in Alzheimer’s Disease
por: Wang, Chong, et al.
Publicado: (2014)

Editorial: Neuroimaging Biomarkers and Cognition in Alzheimer's Disease Spectrum
por: Chen, Jiu, et al.
Publicado: (2022)

Cerebral Pathology and Cognition in Diabetes: The Merits of Multiparametric Neuroimaging
por: van Bussel, Frank C. G., et al.
Publicado: (2017)

Risk factors for subjective cognitive decline: the CABLE study
por: Wen, Chen, et al.
Publicado: (2021)

Potential neuroimaging biomarkers of pathologic brain changes in Mild Cognitive Impairment and Alzheimer’s disease: a systematic review
por: Ruan, Qingwei, et al.
Publicado: (2016)

Neuroimaging Applications for Diagnosis and Therapy of Pathologies in the Central and Peripheral Nervous System
por: Middei, Silvia
Publicado: (2022)

Interleukin-3 is associated with sTREM2 and mediates the correlation between amyloid-β and tau pathology in Alzheimer’s disease
por: Wang, Zhi-Bo, et al.
Publicado: (2022)

Multimodal MRI Neuroimaging Biomarkers for Cognitive Normal Adults, Amnestic Mild Cognitive Impairment, and Alzheimer's Disease
por: Lin, Ai-Ling, et al.
Publicado: (2012)

Genetically determined blood pressure, antihypertensive medications, and risk of Alzheimer’s disease: a Mendelian randomization study
por: Ou, Ya-Nan, et al.
Publicado: (2021)

Neuroimaging advances regarding subjective cognitive decline in preclinical Alzheimer’s disease
por: Wang, Xiaoqi, et al.
Publicado: (2020)

Neuroimage Biomarker Identification of the Conversion of Mild Cognitive Impairment to Alzheimer’s Disease
por: Kung, Te-Han, et al.
Publicado: (2021)

Clinical and cognitive characteristics of preclinical Alzheimer's disease in the Japanese Alzheimer's Disease Neuroimaging Initiative cohort
por: Ihara, Ryoko, et al.
Publicado: (2018)

Association of peripheral neutrophil count with intracranial atherosclerotic stenosis
por: Zhang, Xing, et al.
Publicado: (2020)

Cognitive reserve proxies, Alzheimer pathologies, and cognition
por: Ko, Kang, et al.
Publicado: (2022)

Cerebral Perfusion Insufficiency and Relationships with Cognitive Deficits in Alzheimer’s Disease: A Multiparametric Neuroimaging Study
por: Huang, Chi-Wei, et al.
Publicado: (2018)

Neuroimaging Biomarkers Predicting the Efficacy of Multimodal Rehabilitative Intervention in the Alzheimer’s Dementia Continuum Pathology
por: Di Tella, Sonia, et al.
Publicado: (2021)

Neuroimaging Biomarkers for Alzheimer’s Disease
por: Márquez, Freddie, et al.
Publicado: (2019)

TREML2 Mutation Mediate Alzheimer’s Disease Risk by Altering Neuronal Degeneration
por: Song, Ya-Nan, et al.
Publicado: (2019)

Staging tau pathology with tau PET in Alzheimer’s disease: a longitudinal study
por: Chen, Shi-Dong, et al.
Publicado: (2021)

sTREM2 mediates the associations of minimal depressive symptoms with amyloid pathology in prodromal Alzheimer’s disease: The CABLE study
por: Wang, Zhi-Bo, et al.
Publicado: (2022)

Peripheral immune system in aging and Alzheimer’s disease
por: Cao, Wei, et al.
Publicado: (2018)

An integrated neuroimaging-omics approach for the gut-brain communication pathways in Alzheimer’s disease
por: Sheng, Can, et al.
Publicado: (2023)

Cognition and Neuroimaging in Schizophrenia
por: Calhoun, Vince D., et al.
Publicado: (2012)

Single-Cell RNA Sequencing of Peripheral Blood Reveals Immune Cell Signatures in Alzheimer’s Disease
por: Xu, Hui, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_chdafh0korlgvvf91mtbu7utv2